vTv Therapeutics  logo
vTv Therapeutics VTVT
$ 37.75 -4.53%

Quarterly report 2023-Q2
added 08-11-2023

report update icon

vTv Therapeutics Net Debt 2011-2026 | VTVT

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt vTv Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-11.6 M -12.7 M - 5.34 M 14 M 7.83 M -40.4 M -88 M 34.8 M 82.1 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
82.1 M -88 M -973 K

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Biotechnology industry

Issuer Net Debt Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
163 M - 2.43 % $ 254 M germanyGermany
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-32.7 M $ 1.35 -2.91 % $ 359 M britainBritain
Coherus BioSciences Coherus BioSciences
CHRS
-85.6 M $ 1.61 -3.59 % $ 189 M usaUSA
I-Mab I-Mab
IMAB
-1.06 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
-402 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
2.27 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-4.01 M - -13.47 % $ 169 M franceFrance
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
-706 M $ 24.88 -0.4 % $ 3.04 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
263 K $ 10.02 -1.16 % $ 133 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-6.17 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-824 K - -1.52 % $ 24.7 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
-16.6 M $ 1.57 -0.63 % $ 105 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
114 M - -24.86 % $ 820 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
-34.7 M $ 3.65 1.3 % $ 8.78 B australiaAustralia
Advaxis Advaxis
ADXS
3.42 M - -9.65 % $ 45.9 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
-188 M $ 20.25 -0.54 % $ 2.83 B franceFrance
Adverum Biotechnologies Adverum Biotechnologies
ADVM
31.1 M - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
-19.9 M $ 2.55 -4.14 % $ 16 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
246 M - - - russiaRussia
Dyadic International Dyadic International
DYAI
-6.38 M $ 0.87 - $ 31.5 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-65.1 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
12.6 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-30.2 M - - $ 1.01 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
-7.85 M $ 1.17 -2.1 % $ 64 M israelIsrael
Equillium Equillium
EQ
-29.6 M $ 2.0 -0.5 % $ 115 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-36 M - - $ 26.5 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
-3.44 M $ 0.8 2.49 % $ 27.9 M israelIsrael
AIkido Pharma AIkido Pharma
AIKI
-31.2 M - 1.93 % $ 17.4 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
31.2 M $ 1.15 -3.78 % $ 137 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
-58.8 M $ 26.15 -1.1 % $ 339 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-5.53 M - -45.71 % $ 1.2 M canadaCanada
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
17.7 M $ 6.2 -3.43 % $ 177 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
-39.6 M $ 4.75 -2.59 % $ 299 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
187 M $ 14.46 0.03 % $ 4.46 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-340 M - - $ 3.67 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-783 M - - $ 867 M germanyGermany
BioNTech SE BioNTech SE
BNTX
-973 M $ 88.37 -3.19 % $ 27.2 B germanyGermany
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
-5.45 M $ 3.52 -0.56 % $ 237 B britainBritain
Akouos Akouos
AKUS
-92.9 M - 0.23 % $ 488 M usaUSA
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
-191 M $ 7.45 -4.85 % $ 472 K usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
-25.6 M $ 2.38 -7.03 % $ 152 M usaUSA
Allakos Allakos
ALLK
-25 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-29.5 M - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
-604 M $ 315.4 -4.52 % $ 41.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-63.9 M - - $ 2.17 B usaUSA
Gilead Sciences Gilead Sciences
GILD
14.7 B $ 138.37 -1.26 % $ 172 B usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-3.1 M $ 0.54 4.26 % $ 503 K israelIsrael
Aileron Therapeutics Aileron Therapeutics
ALRN
-3.44 M - 10.36 % $ 9.8 M usaUSA
Genmab A/S Genmab A/S
GMAB
-6.94 B $ 27.13 -2.25 % $ 17 B danmarkDanmark
AlloVir AlloVir
ALVR
-62.7 M - 4.14 % $ 49.1 M usaUSA